
51 - 200 employees
Founded 2013
🧬 Biotechnology
💊 Pharmaceuticals
Biotechnology • Pharmaceuticals
Solid Biosciences is a Charlestown, MA–based precision genetic medicine company focused on developing gene therapies for rare neuromuscular and cardiac diseases. The company advances a portfolio of gene therapy candidates — including SGT-003 for Duchenne muscular dystrophy, SGT-212 for Friedreich’s ataxia, SGT-501 for catecholaminergic polymorphic ventricular tachycardia (CPVT), and SGT-601 for TNNT2-mediated dilated cardiomyopathy — and is developing libraries of genetic regulators and delivery-platform technologies to improve gene therapy delivery. Founded with a patient-focused mission and collaborations across science, technology, and care, Solid emphasizes clinical development, manufacturing infrastructure, and partnerships to bring transformative precision genetic medicines to patients with rare genetic diseases.
🕒 July 10
Senior Regional Medical Director leading Medical Affairs strategy for US-based biotechnology company. Engaging with KOLs and establishing scientific credibility in rare disease therapies.
🕒 July 9
Regional Medical Director for Solid Biosciences, engaging with key opinion leaders and supporting clinical development. Overseeing rare disease initiatives and building US Medical Affairs presence.
🕒 July 9
Lead scientific communications and publication strategy at Solid Biosciences, focusing on gene therapy for rare diseases. Collaborate cross-functionally to maximize scientific impact.
🕒 July 7
Director of Medical Excellence & Operations at Solid Biosciences leading operational backbone of Global Medical Affairs. Responsible for implementing systems, processes, and governance in Medical Affairs.
🕒 June 11
Associate Director overseeing GMP manufacturing for gene therapy products at Solid Biosciences. Leading project management in a fast-paced pharmaceutical environment.